Tag: raw materials

Managing Risks When Specifications Are Not Harmonized During Supplier Qualification Within the pharmaceutical industry, maintaining compliance with established specifications for active pharmaceutical ingredients (APIs) and excipients is critical. Instances of…

CAPA for Compendial Failures: Addressing Unimplemented Pharmacopoeial Changes in Routine Testing The pharmaceutical industry operates under stringent regulatory requirements, emphasizing the importance of adhering to the latest pharmacopoeial standards. However,…

Preventing Repeat Observations Related to Unjustified In-house Specifications during Submission Support The recent trend of raising concerns around unjustified in-house specifications during submission support has underscored the need for robust…

Addressing Non-Harmonized Specifications During Inspection: A Comprehensive Investigation Approach In the pharmaceutical industry, ensuring that materials meet established specifications is critical for maintaining product quality and compliance. Instances of non-harmonized…

Addressing Specification Non-Harmonization During Supplier Qualification: An Investigation Framework In the highly regulated pharmaceutical industry, ensuring the quality and consistency of raw materials and excipients is paramount. A common issue…

Investigating Test Method Non-Compliance During Submission Support to Mitigate Regulatory Risks The pharmaceutical industry operates under stringent regulatory scrutiny, ensuring compliance with guidelines to guarantee product quality, safety, and efficacy.…

Addressing Unjustified In-House Specifications During Routine Testing: A Practical Investigation Approach In the highly regulated pharmaceutical industry, maintaining the integrity of specifications set for raw materials is paramount. Unjustified in-house…

Addressing Non-Implementation of Pharmacopoeial Changes During Routine Testing In the pharmaceutical manufacturing and quality landscape, adhering to updated pharmacopoeial standards is crucial to ensure product safety and efficacy. A scenario…

Addressing Test Method Non-Compliance During Regulatory Inspections In the pharmaceutical manufacturing sector, ensuring compliance with analytical test methods is crucial to maintaining quality and regulatory standards. A scenario can arise…

Addressing Unjustified In-House Specifications during Inspections: A Compliance Gap Analysis The increasing complexity of pharmaceutical manufacturing processes often leads to instances of deviations or non-compliance, particularly concerning in-house specifications that…

Addressing Misuse of Reference Standards During Audit Reviews with CAPA Strategies The misuse of reference standards during audit reviews can introduce significant risks in pharmaceutical manufacturing, particularly impacting the integrity…

Addressing Deviation from Using Outdated Pharmacopoeial Monographs in Routine Testing In the complex landscape of pharmaceutical manufacturing, compliance to the latest pharmacopoeial monographs is critical for ensuring product quality and…